基本信息
views: 55

Bio
Dr. Thomas Milner is one of the early investigators in photomedicine, having made seminal contributions in both surgery and diagnostics. With Institute Medical Director Dr. J. Stuart Nelson, he is one of the inventors of the Institute’s dynamic cooling technology of tissues that has substantially improved the practice of many laser dermatological treatments.
Dr. Milner is a pioneer in introducing novel endogenous contrast mechanisms for optical imaging of tissue. He and his collaborators at the Institute were the first to publish an approach called optical Doppler tomography, which has provided the basis for light-based micro-angiography of the retina and other tissues.
Dr. Milner is an inventor on 55 U.S. patents and five international patents that have been licensed to six companies. He developed and demonstrated novel catheters for intravascular imaging, is a co-inventor of the MasSpec Pen that has been featured worldwide and is a co-founder of CardioSpectra and Dermalucent. His patent royalties to University IP Owners/ Licensees have returned over $100 million and he has authored 190 peer-reviewed articles and eight book chapters.
Dr. Milner was the recipient of the Coherent Young Investigator Award in Biomedical Optics, numerous grants from the National Institutes of Health (NIH) and Inventor of the Year at the University of Texas at Austin. He is a Fellow of the American Society for Laser Medicine & Surgery (ASLMS), American Institute for Medical and Biological Engineering (AIMBE) and the National Academy of Inventors.
Dr. Milner is a pioneer in introducing novel endogenous contrast mechanisms for optical imaging of tissue. He and his collaborators at the Institute were the first to publish an approach called optical Doppler tomography, which has provided the basis for light-based micro-angiography of the retina and other tissues.
Dr. Milner is an inventor on 55 U.S. patents and five international patents that have been licensed to six companies. He developed and demonstrated novel catheters for intravascular imaging, is a co-inventor of the MasSpec Pen that has been featured worldwide and is a co-founder of CardioSpectra and Dermalucent. His patent royalties to University IP Owners/ Licensees have returned over $100 million and he has authored 190 peer-reviewed articles and eight book chapters.
Dr. Milner was the recipient of the Coherent Young Investigator Award in Biomedical Optics, numerous grants from the National Institutes of Health (NIH) and Inventor of the Year at the University of Texas at Austin. He is a Fellow of the American Society for Laser Medicine & Surgery (ASLMS), American Institute for Medical and Biological Engineering (AIMBE) and the National Academy of Inventors.
Research Interests
Papers共 537 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Lasers in Medical Scienceno. 1 (2025): 1-10
Paul Young, Drew Nolen,Thomas E Milner, Alexandra Gruslova,Deborah Vela, Louis Maximilian Buja, Luis A Diaz Sanmartin, Paul Rad, Marc D Feldman
Journal of the Society for Cardiovascular Angiography & Interventionsno. 3Part B (2025): 102524-102524
Journal of endourology (2025)
MEDICAL PHYSICSno. 10 (2024): 7715-7715
Cited0Views0Bibtex
0
0
Frontiers in Photonics (2024)
Photonics in Dermatology and Plastic Surgery 2024 (2024)
Andrei Dragos Cumpanas,Nitesh Katta,Yi Xi Wu,Antonio R. H. Gorgen,Jacob C. Tsai, Thao N. Vu,Mariah C. Hernandez,Kelvin Vo, Jaime Altamirano Villaroel,Bruce Gao,Zachary E. Tano,Pengbo Jiang,Roshan M. Patel,Thomas Milner,Jaime Landman,Ralph V. Clayman
Glori Das,Thomas E. Milner
Frontiers in Photonics (2024)
Advanced Photonics in Urology 2024 (2024)
Load More
Author Statistics
#Papers: 537
#Citation: 17029
H-Index: 67
G-Index: 117
Sociability: 7
Diversity: 3
Activity: 17
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn